350 related articles for article (PubMed ID: 8199988)
1. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
[TBL] [Abstract][Full Text] [Related]
2. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
3. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
4. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
Lamb RF; Going JJ; Pickford I; Birnie GD
Cancer Res; 1996 Feb; 56(4):916-20. PubMed ID: 8631033
[TBL] [Abstract][Full Text] [Related]
5. The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study.
Cohn KH; Ornstein DL; Wang F; LaPaix FD; Phipps K; Edelsberg C; Zuna R; Mott LA; Dunn JL
Cancer; 1997 Jan; 79(2):233-44. PubMed ID: 9010096
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
Eur J Cancer; 1994; 30A(5):664-70. PubMed ID: 8080684
[TBL] [Abstract][Full Text] [Related]
7. Somatic allelic deletion of nm23 in human cancer.
Leone A; McBride OW; Weston A; Wang MG; Anglard P; Cropp CS; Goepel JR; Lidereau R; Callahan R; Linehan WM
Cancer Res; 1991 May; 51(9):2490-3. PubMed ID: 2015608
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer.
Heide I; Thiede C; Poppe K; de Kant E; Huhn D; Rochlitz C
Br J Cancer; 1994 Dec; 70(6):1267-71. PubMed ID: 7981087
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of the promoter region of human nm23-H1, a metastasis suppressor gene.
Chen HC; Wang L; Banerjee S
Oncogene; 1994 Oct; 9(10):2905-12. PubMed ID: 8084595
[TBL] [Abstract][Full Text] [Related]
11. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.
Cawkwell L; Lewis FA; Quirke P
Br J Cancer; 1994 Nov; 70(5):813-8. PubMed ID: 7947085
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity for Rb, TP53, and chromosome arm 3p, but not NME1 in squamous cell carcinomas of the supraglottic larynx.
Scholnick SB; Sun PC; Shaw ME; Haughey BH; el-Mofty SK
Cancer; 1994 May; 73(10):2472-80. PubMed ID: 8174043
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas.
Bosnar MH; Pavelić K; Hrasćan R; Zeljko Z; Krhen I; Marekoyic Z; Krizanac S; Pavelíc J
J Cancer Res Clin Oncol; 1997; 123(9):485-8. PubMed ID: 9341897
[TBL] [Abstract][Full Text] [Related]
14. Localization of a second NM23 gene, NME2, to chromosome 17q21-q22.
Kelsell DP; Black DM; Solomon E; Spurr NK
Genomics; 1993 Aug; 17(2):522-4. PubMed ID: 8406509
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implication of nm23-H1 expression in colorectal carcinomas.
Dursun A; Akyürek N; Günel N; Yamaç D
Pathology; 2002 Oct; 34(5):427-32. PubMed ID: 12408341
[TBL] [Abstract][Full Text] [Related]
17. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
[TBL] [Abstract][Full Text] [Related]
19. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma.
Cohn KH; Wang FS; Desoto-LaPaix F; Solomon WB; Patterson LG; Arnold MR; Weimar J; Feldman JG; Levy AT; Leone A
Lancet; 1991 Sep; 338(8769):722-4. PubMed ID: 1679868
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
